| Date Filed | Type | Description |
| 10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Fitzpatrick Alexander A (Chief Legal Officer) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 700,000 options to buy
@ $8.42, valued at
$5.9M
|
|
| 12/01/2022 |
3
| Fitzpatrick Alexander A (Chief Legal Officer) has filed a Form 3 on ARS Pharmaceuticals, Inc. |
| 02/23/2022 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 300,000 shares
@ $0
Granted 300,000 options to buy
@ $0.49, valued at
$147k
|
|
| 01/04/2022 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Disposed/sold 120,000 shares
@ $0 |
|
| 12/20/2021 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Bought 25,000 shares
@ $0.389, valued at
$9.7k
|
|
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2020 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Bought 9,090 shares
@ $2.2, valued at
$20k
|
|
| 06/08/2020 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 31,590 shares
@ $3.31, valued at
$104.6k
|
|
| 05/26/2020 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 39,487 shares
@ $4.99, valued at
$197k
|
|
| 05/08/2020 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 7,802 shares
@ $5.24, valued at
$40.9k
|
|
| 02/07/2020 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 150,000 shares
@ $0
Granted 100,000 options to buy
@ $4.87, valued at
$487k
|
|
| 11/26/2019 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 7,747 shares
@ $6.22, valued at
$48.2k
|
|
| 11/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2019 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 18,427 shares
@ $5.01, valued at
$92.3k
|
|
| 08/26/2019 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 1,296 shares
@ $5.13, valued at
$6.6k
|
|
| 06/12/2019 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 7,777 shares
@ $6.36, valued at
$49.5k
|
|
| 04/03/2019 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 1,298 shares
@ $3.55, valued at
$4.6k
|
|
| 02/27/2019 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 50,000 shares
@ $0 |
|
| 12/03/2018 |
4/A
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 100,000 options to buy
@ $3.45, valued at
$345k
|
|
| 11/29/2018 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted options to buy
@ $3.45, valued at
$0 |
|
| 10/17/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/21/2018 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Bought 4,500 shares
@ $2.2, valued at
$9.9k
Bought 500 shares
@ $2.27, valued at
$1.1k
|
|
| 07/03/2018 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 70,000 shares
@ $0 |
|
| 03/14/2018 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 275,000 options to buy
@ $7.29, valued at
$2M
|
|
| 01/18/2018 |
3
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 3 on Evofem Biosciences, Inc. |
| 11/04/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/02/2013 |
4
| Fitzpatrick Alexander A (Sr. VP General Counsel) has filed a Form 4 on VERENIUM CORP|
Txns:
| Granted 25,000 options to buy
@ $2.18, valued at
$54.5k
|
|
| 08/03/2012 |
4
| Fitzpatrick Alexander A (SVP & General Counsel) has filed a Form 4 on VERENIUM CORP|
Txns:
| Granted 20,000 options to buy
@ $4.23, valued at
$84.6k
|
|
| 08/22/2011 |
4
| Fitzpatrick Alexander A (SVP & General Counsel) has filed a Form 4 on VERENIUM CORP|
Txns:
| Bought 293 shares
@ $1.85, valued at
$542.1
Bought 7,203 shares
@ $1.9, valued at
$13.7k
|
|
| 07/29/2011 |
4
| Fitzpatrick Alexander A (SVP & General Counsel) has filed a Form 4 on VERENIUM CORP|
Txns:
| Granted 50,000 options to buy
@ $1.62, valued at
$81k
|
|
| 11/12/2010 |
4
| Fitzpatrick Alexander A (SVP & General Counsel) has filed a Form 4 on VERENIUM CORP|
Txns:
| Granted 25,000 options to buy
@ $3.84, valued at
$96k
|
|